Chemoinformaics analysis of 7-CYCLOPENT-2-EN-1-YLHEPTANOIC ACID
| Molecular Weight | 196.29 | nRot | 7 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 19 |
| Exact Molecular Weight | 196.146 | nRing | 1 |
| Solubility: LogS | -2.053 | nHRing | 0 |
| Solubility: LogP | -0.556 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 34.9799 |
| nHD | 1 | BPOL | 20.9321 |
| QED | 0.181 |
| Synth | 4.243 |
| Natural Product Likeliness | 1.681 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.939 |
| HIA | 0.886 |
| CACO-2 | -5.844 |
| MDCK | 0.000109173 |
| BBB | 0.536 |
| PPB | 0.371437 |
| VDSS | 0.347 |
| FU | 0.237796 |
| CYP1A2-inh | 0.009 |
| CYP1A2-sub | 0.083 |
| CYP2c19-inh | 0.005 |
| CYP2c19-sub | 0.752 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.331 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.368 |
| CYP3a4-inh | 0.009 |
| CYP3a4-sub | 0.069 |
| CL | 2.222 |
| T12 | 0.597 |
| hERG | 0.144 |
| Ames | 0.088 |
| ROA | 0.04 |
| SkinSen | 0.038 |
| Carcinogencity | 0.138 |
| EI | 0.006 |
| Respiratory | 0.004 |
| NR-Aromatase | 0.789 |
| Antiviral | No |
| Prediction | 0.53782 |